Third-party testing for creatine: read what was actually checked

A company can describe its own checks, commission laboratory analysis or participate in an independent certification program. These descriptions are not synonyms. A statement that testing happened does not, without further detail, identify the sample, analytes, acceptance limits or continuing oversight involved. Asking for the underlying record is a request for specificity, not an allegation of contamination.

NIH’s supplement overview explains that independent quality programs may evaluate manufacture, listed ingredients and contaminant levels. It also says their seals do not guarantee that a product is safe or effective. NIH quality explanation That explicit limit should survive even when a seller displays a mark prominently.

NSF’s current program description includes formulation and label review, confirmation of contents, screening for banned substances, facility and supplier inspections, and continuing monitoring. Its mark explanation also addresses unacceptable contaminant levels. These are concrete quality-related checks with a defined program behind them. NSF certification process NSF mark scope

The appropriate claim follows that scope. It is not that the issuer ran a trial showing fewer falls, stronger bones or better mobility in all older adults. A contaminant standard also should not be paraphrased as proof that literally no contaminant can exist. The program’s own language and the exact listed product remain necessary qualifications.

NSF’s current Thorne Creatine listing identifies an unflavored powder, package sizes and a serving description, and includes named lot records. That is more specific than a brand-wide claim that everything a company sells carries the same certification. Exact NSF Thorne entry

The Thorne product review relates this public entry to the named retail version. We have not inspected a delivered container or authenticated a lot in someone’s possession. A matching product description supports a limited documentary comparison; it does not certify an unseen purchase. If the name, format or label version differs, the difference should remain visible until the issuer or company clarifies it.

Product records can change while an older image or document remains available. A new ingredient supplier, renamed formulation or changed package can create a question about which exact record applies. That question cannot be settled by recognizing the brand alone, and it should not automatically be recast as evidence that certification has disappeared.

Our Momentous review examines current product wording and its relationship to the available issuer material. This kind of source comparison asks whether the documents align; it does not independently analyze the powder. The serving and container guide uses the same discipline for amounts and package descriptions.

Strong Suit’s page says it is manufactured in an FDA-registered facility. That is the seller’s manufacturing statement, not a displayed independent lot analysis or a grant of FDA approval to the supplement. FDA explains that it does not approve dietary supplements for safety and effectiveness, or approve their labels, before sale. Strong Suit public record FDA regulatory explanation

Regulation still exists: FDA describes company responsibilities, inspections and action against unsafe or unlawful products. It is therefore misleading both to treat facility wording as approval and to suggest that absence of premarket approval means there are no regulatory obligations. Neither position establishes the contents of an individual tub.

A product-quality record and a randomized trial have different subjects. The former concerns a specified product and program requirements. The latter concerns participants, an intervention, a comparator and outcomes. A well-matched certificate cannot fill gaps in evidence about a clinical goal, just as a favorable ingredient trial cannot authenticate a retail lot.

The older-adult research guide examines a trial with exercise in both groups and different findings for bone density, walking and strength. None of those results becomes a brand ranking through certification. The fixed evidence reader keeps the source’s subject next to its limitation so that two useful kinds of evidence are not merged.

An effective question identifies what is missing: the issuer’s entry for the precise version, the relation between a listed lot and supplied label, or clarification of what a test measured. A professional can then consider product information alongside the person’s health and goals. This guide provides no pass/fail clearance or recommendation to take a particular powder.

Long Game Strength’s first CoreAge placement is commercial and comes with the disclosed publishing-network relationship. It does not mean CoreAge has a stronger certification record, superior purity or better outcomes than another option. The product comparison records differences and gaps without turning the presence or absence of a mark into a clinical winner.